Al-Zahrawi

Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing

Retrieved on: 
Tuesday, November 28, 2023
Ministry, Research, Ministry of Health (Bahrain), Al-Zahrawi, Emerging market, Genomics, Supreme Council, GCC, Harvard University, Medical device, Health, Illumina, Kingdom

MANAMA, Bahrain, Nov. 28, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom of Bahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes.

Key Points: 
  • MANAMA, Bahrain, Nov. 28, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom of Bahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes.
  • The move is part of the Kingdom's commitment to continue developing therapeutic and diagnostic services in line with latest global medical advancements, benefiting the health of all.
  • The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the National Genome Project, which aims to utilize gene sequencing in adopting effective national health policies and therapeutic and preventative management plans.
  • A national delegation of specialists from the National Genome Centre was sent to Harvard University in the United States to undergo specialized training, including the latest methods of genome sequencing, biological data classification, clinical analysis, scientific data analysis, and genetic data management.

Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing

Retrieved on: 
Tuesday, November 28, 2023
Ministry, Research, Ministry of Health (Bahrain), Al-Zahrawi, Emerging market, Genomics, Supreme Council, GCC, Harvard University, Medical device, Health, Illumina, Kingdom

MANAMA, Bahrain, Nov. 28, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom of Bahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes.

Key Points: 
  • MANAMA, Bahrain, Nov. 28, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom of Bahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes.
  • The move is part of the Kingdom's commitment to continue developing therapeutic and diagnostic services in line with latest global medical advancements, benefiting the health of all.
  • The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the National Genome Project, which aims to utilize gene sequencing in adopting effective national health policies and therapeutic and preventative management plans.
  • A national delegation of specialists from the National Genome Centre was sent to Harvard University in the United States to undergo specialized training, including the latest methods of genome sequencing, biological data classification, clinical analysis, scientific data analysis, and genetic data management.

MedX Health Corp. Announces Third Quarter 2021 Results

Retrieved on: 
Monday, November 29, 2021
Biotechnology, Health, Clinical Trials, Other Health, Health, CE, Company, TSX Venture Exchange, Legislation, Physician, GP, Board of directors, Board, Medarex, Medtronic, CEO, Time, Dermatology, Johnson & Johnson, TGA, MOU, United Kingdom, Covidien, Pharmacy, Caregiver, Insurance, Sale, European Union, Smith & Nephew, Partnership, Health Canada, Clinical trial, Aircraft, CFO, Director, FDA, Growth, Patient, Adoption, Global Health Corps, SEDAR, Technology, Acquisition, Burns, Pain, Al-Zahrawi, Organization, Union, Privacy, Light, Moles, Animal, Management, Medical device, Mobile phone, Pharmaceutical industry, Airline

MedX Health Corp. (MedX or the Company) (TSXV: MDX) announced its results for the three and nine months ended September 30, 2021, which are also available on SEDAR ( www.sedar.com ).

Key Points: 
  • MedX Health Corp. (MedX or the Company) (TSXV: MDX) announced its results for the three and nine months ended September 30, 2021, which are also available on SEDAR ( www.sedar.com ).
  • Third Quarter 2021 Financial Highlights:
    The Company reported revenue of $94,146 for the three months ended September 30, 2021, compared with revenue of $172,889 for the three months ended September 30, 2020.
  • The MedX and Vitamed pilot program in Italy is expected to be in-market for 60 days from October to November 2021.
  • MedX Announces Board Changes (August 23, 2021)
    The Company announces changes to its Board of Directors.